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Abstract 
Controlled hypotension or induced hypotension is a technique to reduce the blood loss and the necessity of blood 
transfusion during surgery by improving the visibility of the surgical site and decreasing the arterial blood pressure 
until hypotension is reached. Hence based on above findings the present study was planned for Evaluation of 
Controlled Hypotensive Anesthesia in spine surgeries by Comparative Administration of Dexmedetomidine and 
Nitroglycerine.The present study was planned in Department of Anaesthesia, Vardhman Institute of Medical Science 
Pawapuri. Nalanda, Bihar. The study was conducted from November 2015 to December 2016. In the present study 
total 40 patients were selected undergoing the spine surgeries were evaluated. The cases were divided in two study 
groups as Group D and Group N. The study drug dexmeditomidine was given to group D in the dose of 1 micro 
gram/kg body weight in a 600 seconds infusion before induction diluted to 10 ml with normal saline followed by 
maintenance dose at infusion rate of 0.2 - 0.7 microgm/kg. The group N received 10 ml plain normal saline over 600 
seconds before induction The data generated from the present study concludes that Controlled hypotension using 
dexmeditomidine as bolus dose 1 microgram per kg intravenous over 10 minutes prior to induction followed by 
continuous intravenous infusion at 0.2 - 0.7 microgram per kg per hour, provided more stable hemodynamics and 
better surgical field quality compared to nitroglycerine intraoperative infusion at 0.5 to 10 microgram/kg/min. 
Keywords:Controlled Hypotensive Anesthesia, Dexmedetomidine, Nitroglycerine, spine surgeries, etc. 
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Introduction 
In recent decades, increased understanding of spinal 
biomechanics, proliferation of sophisticated spinal 
instrumentation devices, advances in bone fusion 
techniques, refinement of anterior approaches to the 
spine, and development of microsurgical and 
minimally invasive methods have made it possible to 
stabilize every segment of the spine successfully, 
regardless of the offending pathology. Accordingly, 
use of spinal fusion and instrumentation has increased. 
The question facing the modern spine surgeon is not so 
much how to stabilize the spine but when to do so. 
__________________ 
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As defined by White and Panjabi, [1]  spinal stability is 
the ability of the spine under physiologic loads to limit 
patterns of displacement so as not to damage or irritate 
the spinal cord and nerve roots and, in addition, so as to 
prevent incapacitating deformity or pain due to 
structural changes; instability (acute or chronic) refers 
to excessive displacement of the spine that would result 
in neurologic deficit, deformity, or pain. 
It should be noted that whereas the term fusion, as used 
in this article and in spine literature to refer to the 
concept of internal stabilization of the spine, generally 
refers to fusion with instrumentation (instrumented 
fusion), such stabilization has also, albeit with 
decreasing frequency, been accomplished by means of 
bone grafting alone. 
A great deal of controversy remains regarding the 
application of fusion surgery in the treatment of 
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degenerative spine disease without overt instability. In 
the future, these controversies will be addressed by a 
two-pronged approach. First, rigorous randomized 
controlled trials are needed to better assess the efficacy 
of existing methods of fusion. Second, novel treatment 
strategies are needed to replace fusion surgery. 
Disk arthroplasty and posterior dynamic stabilization 
devices are two strategies that are under investigation. 
Some brands of artificial disk (see the image below) for 
treatment of symptomatic lumbar degenerative disk 
disease have been approved by the US Food and Drug 
Administration (FDA). Short-term studies revealed 
equivalent results for disk arthroplasty and lumbar 
fusion. [2] 
A prospective, randomized, controlled multicenter 
study designed to show the "noninferiority" of cervical 
total disk replacement (TDR) revealed that this 
technology was at least equivalent to anterior cervical 
diskectomy and fusion with regard to outcome at 24 
months. [3]  Although most primary outcome measures 
(eg, pain scores and neurologic success) were 
equivalent in the two groups, the disk replacement 
group showed a lower requirement for analgesics and 
lower reoperation rate than the fusion group at 24 
months. 
Although these results show promise for total disk 
replacement, it should be noted that this study was 
limited to patients with single-level disk disease with 
radiculopathy and and that the results therefore cannot 
be generalized to patients with multilevel disk 
herniations, spondylosis, spondylolisthesis, and 
degenerative disk disease. In addition, long-term 
follow-up studies are needed to determine whether 
these benefits last, whether motion preservation with 
artificial disks persists over the long term, and whether 
the frequency of transition-level syndrome is 
decreased. 
Posterior dynamic stabilization devices come in several 
varieties. The most promising of these are pedicle 
screw-based systems, where the screws are linked by 
flexible members instead of rigid rods. The theoretical 
goal is to limit movement to a zone where neutral or 
near-neutral loading of spine occurs, or conversely 
prevent movement into a zone where abnormal loading 
occurs. Again, the clinical trials that have been 
conducted to date have produced clinical outcomes 
comparable with fusion. [4] 
The challenges facing artificial disks and posterior 
dynamic stabilization devices are twofold. First, they 
must improve upon lumbar fusion outcomes. Second, 
these mechanical devices must continue to function 
indefinitely, as opposed to current spine implants, 
which are shielded from biomechanical stress once 
bony fusion is achieved. 
In the long-term future, biologic rather than mechanical 
treatment strategies directed at repairing and 
maintaining the degenerated spine elements are more 
likely to provide a satisfactory solution to the problem 
of degenerative spine disease.Regional variations in 
vertebral anatomy affect the incidence and 
consequences of spinal instability in different parts of 
the spine and dictate the surgical means by which the 
spine can be stabilized. 
Vertebral body size increases as one descends the 
spine, accompanied by a corresponding increase in 
vertebral axial load-bearing capacity. The greater 
cancellous-to-cortical bone ratio in the vertebral body 
as compared with the posterior vertebral elements 
makes the body more susceptible to neoplastic and 
infectious diseases, and its relation to the instantaneous 
axis of rotation (IAR) makes it more susceptible to 
compressive injuries. The relative preponderance of 
these disorders anterior to the spinal cord makes their 
surgical management more challenging, often 
necessitating an anterior surgical approach to the spine. 
On the other hand, the large surface area and volume of 
the vertebral body make it an excellent target for 
insertion of screw/plate systems, which can be used to 
stabilize every segment of the subaxial spine. 
Facet joints have a transverse orientation in the cervical 
spine and gradually acquire a more sagittal orientation 
throughout the thoracic and upper lumbar spine. They 
then become more coronally oriented as one descends 
the lumbar spine. The transverse orientation of the 
facet joints and the loose facet capsules in the cervical 
spine allow relatively free movement of the neck in all 
three planes and do not protect the cervical spine 
against flexion injuries. 
In the thoracolumbar junction, the sagittal orientation 
of the facet joints and the strong capsular ligaments 
permit greater movement in the sagittal plane than in 
other directions. This facet orientation and the 
transitional location of the thoracolumbar spine 
between the ribcage-stabilized thoracic spine and the 
more robust lumbar spine make the thoracolumbar 
junction more susceptible to flexion injuries. 
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The more coronal orientation of the L5-S1 facet joints 
as compared with the L4-5 facets accounts for the 
lower incidence of degenerative spondylolisthesis at 
L5-S1, in spite of the biomechanically disadvantaged 
angle of the lumbosacral junction. In contrast, isthmic 
spondylolisthesis, where the presence of spondylolysis 
bypasses the resistance of facet joints against 
translation, is more frequent at L5-S1. 
The spinal canal is narrowest in the thoracic spine. On 
the other hand, the thoracic spine is stabilized by the 
ribcage, making it relatively immune to degenerative 
instability and increasing its resistance to traumatic 
instability. Consequently, if the force vector is great 
enough to overcome the stability of thoracic spine and 
produce a fracture-dislocation, the likelihood and 
severity of spinal cord injury would be greater in this 
area than elsewhere in the spine. 
The pedicles in the cervical spine are quite narrow, 
short, acutely oriented, and juxtaposed to the transverse 
foramina (of the vertebral artery); accordingly, they are 
relatively undesirable for screw insertion. In contrast, 
the large size, strength, and favorable cylindrical 
anatomy of the pedicles in the lumbar spine makes 
them ideal for screw insertion. The pedicle screws at 
different segments are then linked by rods to stabilize 
the spine. 
The pedicles acquire a relatively sagittal orientation in 
the thoracic and upper lumbar spine but then point 
inward again as one approaches the sacrum, a fact that 
must be taken into account when pedicle screws are to 
be inserted. In the thoracic spine, the pedicles have a 
narrow transverse diameter, exhibit a slight downward 
angle, and are located next to the narrow thoracic 
spinal canal. 
Because of these anatomic considerations, wires and 
hooks have been used more frequently than screws to 
anchor rods against the thoracic spine, necessitating 
long instrumentation constructs to stabilize a short 
segment of instability ("rod long, fuse short"). 
Increasingly, screws are used in the thoracic spine to 
create shorter and stronger instrumentation constructs. 
In this setting, it is imperative to select screws of 
appropriate diameter on the basis of preoperative 
computed tomography (CT) and to avoid breach of the 
medial pedicle wall, erring toward the laterally located 
and protective costovertebral articulation, if necessary. 
On the other hand, the relatively generous sagittal 
diameter of thoracic pedicles and the smaller size and 
lesser functional importance of thoracic nerve roots 
make screw misdirection in the sagittal plane less 
costly in the thoracic spine than it would be in the 
lumbar spine. 
Cervical vertebrae have anatomic structures not found 
elsewhere in the spine: the lateral masses. Juxtaposed 
between the pedicles and the lamina and delimited by 
the articular surfaces of the adjacent facet joints, the 
paired lateral masses are satisfactory targets for screw 
insertion. Lateral mass screws at adjacent segments are 
linked by plates or rods to stabilize the cervical spine. 
Laminae, spinous processes, and transverse processes 
can be used as anchor points for wires and hooks 
connected to rods to form three-point-bending 
instrumentation constructs. Alternatively, these 
structures can be wired to each other at different 
segments to produce tension band constructs. In 
general, these types of constructs provide less stiffness 
than screw/rod or screw/plate systems. 
Controlled hypotension or induced hypotension is a 
technique to reduce the blood loss and the necessity of 
blood transfusion during surgery by improving the 
visibility of the surgical site and decreasing the arterial 
blood pressure until hypotension is reached. Hence 
based on above findings the present study was planned 
for Evaluation of Controlled Hypotensive Anesthesia 
in spine surgeries by Comparative Administration of 
Dexmedetomidine and Nitroglycerine. 
Methodology 
The present study was planned in Department of 
Anaesthesia, Vardhman Institute of Medical Science 
Pawapuri. Nalanda, Bihar. The study was conducted 
from November 2015 to December 2016.In the present 
study total 40 patients were selected undergoing the 
spine surgeries were evaluated. The cases were divided 
in two study groups as Group D and Group N. The 
study drug dexmeditomidine was given to group D in 
the dose of 1 micro gram/kg body weight in a 600 
seconds infusion before induction diluted to 10 ml with 
normal saline followed by maintenance dose at 
infusion rate of 0.2 - 0.7 microgm/kg. The group N 
received 10 ml plain normal saline over 600 seconds 
before induction followed by maintenance dose of 
nitroglycerine at an infusion rate of 0.5 - 10 
microgm/kg/min. 
The 50 ml syringe were labelled as LD and MD for 
laoding dose and maintenanace dose respectively. For 
patients in group D X, LD syringe contained the bolus 
dose of dexmedetomidine at 1 microgm /kg diluted to 
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10 ml with required amount of normal saline and MD 
had 2 microgm /kg prepared by taking 1 ml (100 
microgm) of inj. dexmeditomidine diluted with 49 ml 
of normal saline. For group N G patients, LD syringe 
had 10 ml of plain normal saline and MD had 100 
microgm/ml of nitroglycerin prepared by taking 1 ml 
(5 mg) of nitroglycerin diluted with 49 ml of normal 
saline. The anaesthesiologist responsible for providing 
anaesthesia and observing the parameters during the 
surgery and the patient were kept unaware of the 
content of the syringes. After arrival in the 
preanaesthesia room 20 G and 18 Gintravenous 
cannula were inserted at different anatomical sites for 
the infusion of the study drug and for the 
administration of fluids and other drug/ blood 
respectively. 
All the patients were informed consents. The aim and 
the objective of the present study were conveyed to 
them. Approval of the institutional ethical committee 
was taken prior to conduct of this study. 
Following was the inclusion and exclusion criteria for 
the present study. 
Inclusion Criteria: Cases belonging to ASA class I or II 
between 18 and 60 years of age scheduled for elective 
spine surgeries. 
Exclusion criteria: Cases of ASA grade III, IV, 
uncontrolled diabetes mellitus, pulmonary disease, 
uncontrolled hypertension, ischemic heart disease, 
gastro-esophageal reflux disease, cerebral ischemia and 
renal impairment. History of difficult airway 
management. Body mass index >40, history of 
neuromuscular disease, pregnancy.  Known allergy to 
all study drugs. Prior treatment with calcium channel 
blockers, opioids, anticoagulants and patients receiving 
magnesium supplementation or drugs known to have a 
significant interaction with NMDAs.  
Results and Discussion 
Controlled hypotension involves reducing arterial 
blood pressure 30-40% below its normal range or 
reducing mean arterial pressure (MAP) to 65 mmHg 
reversibly and maintaining it at that level throughout 
the surgery. [5] A variety of medications can be used to 
induce intra-operative hypotension including 
vasodilators like sodium nitroprusside, [6] 
nitroglycerin [7] and hydralazine; inhaled anesthetics 
like isoflurane [8] and sevoflurane; intravenous 
anesthetics like propofol; beta adrenergic antagonists 
like esmolol; [9] trimethaphan, adenosine and α2 
agonists. Some of the reported disadvantages with the 
use of these agents include resistance to vasodilators, 
tachyphylaxis with nitroglycerin, cyanide toxicity with 
the use of nitroprusside and delayed recovery from 
anesthesia with the use of high doses of inhaled 
anesthetics. [10] 
An important technique to reduce bleeding during the 
surgery is controlled reduction in blood pressure to 
such levels so that bleeding is minimal, but at the same 
time perfusion to the vital organs is well-maintained. 
This is the underlying concept for controlled 
hypotensive anesthesia. [11] Reduced bleeding in the 
operative site improves the quality of the surgical field, 
decreases the number of manipulations as well as the 
incidence of major complications and shortens the 
surgical time. [12] 
Dexmedetomidine, a selective α2 adrenoceptor agonist, 
causes reduction in blood pressure, slowing of HR, 
sedation and analgesia. The fall in blood pressure is 
mainly due to inhibition of central sympathetic outflow 
and also due to stimulation of presynaptic α2 
adrenoceptors decreasing norepinephrine release. [13] 
An important advantage is its minimal respiratory 
depressant effect with potent sedative and analgesic 
effects compared with opioids and other sedatives. A 
few studies have shown that dexmedetomidine 
decreases the bleeding in surgeries within the 
framework of hemodynamic stability. [14] 
Table 1: Basic Details 
Group Group D Group N 
Administration of  Dexmeditomidine Nitroglycerine 
Group of  Cases Control 
No. of Cases 20 20 
Age (years) 29 – 46 31 - 45 
Sex: 
Males 
Females 
 
12 
8 
 
15 
5 
Weight (kg) 51.2 – 63.8 54.1 – 72.3 
BMI (kg/m2) 20.5 – 24.7 21.1 – 24.9 
Baseline Hear Rate  85 – 104 79 – 109 
Mean arterial pressure (mm hg) 93.4 – 101.5 90.4 – 102.3 
Duration of Surgery (min) 70.1 – 85.9 69.5 – 91.3 
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Table 2: Fromme Boezaart surgical field grade 
Group Group D Group N 
Administration of  Dexmeditomidine Nitroglycerine 
Group of  Cases Control 
No. of Cases 20 20 
 15 min 30 min 45 min 15 min 30 min 45 min 
Grade 0 0 0 0 0 0 0 
Grade 1 0 2 1 0 0 0 
Grade 2 16 17 18 8 10 14 
Grade 3 4 1 2 12 10 6 
Grade 4 0 0 0 0 0 0 
Grade 5 0 0 0 0 0 0 
 
Table 3: Heart Rate changes 
Group Group D Group N 
Administration of  Dexmeditomidine Nitroglycerine 
Group of  Cases Control 
No. of Cases 20 20 
Heart Rate bpm   
Baseline 85 – 103 79 – 102 
Start of surgery 65 – 84 88 – 122 
End of surgery 63 – 66 78 – 106 
15 mins post extubation 71 – 78 96 - 110 
 
Table 4: Mean arterial pressure 
Group Group D Group N 
Administration of  Dexmeditomidine Nitroglycerine 
Group of  Cases Control 
No. of Cases 20 20 
Mean arterial pressure mm hg   
Baseline 93 – 102 90 – 102 
Start of surgery 70 – 74 86 – 95 
End of surgery 68 – 74 69 – 78 
15 mins post extubation 76 – 80 88 - 101 
 
Jamaliya et al. [15] found that continuous infusion of 
dexmedetomidine is effective in minimizing blood loss 
and maintaining superior haemodynamics as comparied 
with nitroglycerine in posterior fixation spine surgery. 
Nasreen et al. [16] in study assessing the hypotensive 
effect of dexmedetomidine administered s a 0.4 
µg/kg/h IV infusion following a 1 µg/kg IV bolus dose 
in middle ear surgery, it has been reported that surgeon 
satisfaction was increased and inhalation agent 
necessity to decrease the mean arterial pressure up to 
30% was decreased in dexmedetomidine administered 
patient group. Secondary decrease in the heart rate and 
blood pressure caused by dexmedetomidine is 
considered to be responsible for this situation.  
In study conducted by Vali et al. [17] comparing 
dexmedetomidine with nitroglycerine in patients 
undergoing posterior fixation surgery after traumatic 
spine fractures dexmedetomidine had better control 
over vital parameters e.g heart rate, mean arterial 
pressure, systolic blood pressure and diastolic blood 
pressure than nitroglycerine. In study conducted by 
Rokhtabnak et al. [17] compring dexmedetomidine 
with magnesium sulfate, blood pressure control was 
easier in the dexmedetomidine group that`s number of 
patients that required nitroglyerine or analgesic rescue 
administration was lower in dexmedetomidine group. 
As regard duration of surgery there was stastically 
significant difference with duration of surgery shorter 
in dexmedetomidine group followed by magnesium 
sulfate group then nitroglycerine group. These results 
suggest that dexmedetomidine is the best regard visual 
field and duration of surgery.  
With agreement to these results, study conducted by 
Vali et al. [17] to compare dexmedetomidine and 
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nitroglycerine in posterior fixation surgery following 
traumatic spine surgery showed that surgeries in 
nitroglycerine group lasted for longer duration than 
dexmedetomidine group with difference being 
stastically significant 
The Khalifa et al. [19] also observed no significant 
difference in amount of blood loss in dexmedetomidine 
group, nitroglycerine group as well as magnesium 
sulphate group. Our results were in contrast with the 
result of Jamaliya et al. [20]. Нey observed that amount 
of blood loss and blood transfusion requirement were 
significantly higher in NTG group than in DEX group. 
Actually they carried out this study in spine surgeries 
and blood loss in spine surgery is mainly dependent on 
congestion of veins around the vertebral bodies. NTG 
is a peripheral vasodilator agent with its predominant 
select on veins. Dilatation of the venous plexus around 
the vertebral bodies may have contributed to increased 
blood loss when NTG was used for controlled 
hypotension. Durmus et al. [21] have proved in a 
placebo controlled study that dexmedetomidine 
decreased bleeding in patients undergoing 
tympanoplasty and septorhinoplasty. 
Many anesthetic agents and vasoactive drugs are used 
frequently to produce controlled hypotension, 
including inhalational anesthetics, direct-acting 
vasodilators, autonomic ganglion blockers, β-
adrenergic blockers, and calcium channel blockers. It 
was in 1985 M Guggiari et al., used nitroglycerine 
(NTG) [22] for the first time to produce induced 
hypotension in aneurismal brain surgery and proved 
that it can be used as a sole agent for hypotension. The 
decrease in arterial pressure is achieved by vasodilatory 
effect of NTG on arterial and venous bed resulting 
finally in decreased venous and right heart filling and 
so decreased cardiac output.Nitroglycerine causes 
either no change or slight tachycardia during 
continuous infusion as slight increase in heart rate is 
reflex phenomenon, baroreceptor response secondary 
to hypotension produced. 
An important technique to reduce bleeding during the 
surgery is controlled reduction in blood pressure to 
such levels so that bleeding is minimal, but at the same 
time perfusion to the vital organs is well-maintained. 
This is the underlying concept for controlled 
hypotensive anesthesia. [23] Reduced bleeding in the 
operative site improves the quality of the surgical field, 
decreases the number of manipulations as well as the 
incidence of major complications and shortens the 
surgical time. [24] 
 
 
Conclusion 
The data generated from the present study concludes 
that Controlled hypotension using dexmeditomidine as 
bolus dose 1 microgram per kg intravenous over 10 
minutes prior to induction followed by continuous 
intravenous infusion at 0.2 - 0.7 microgram per kg per 
hour, provided more stable hemodynamics and better 
surgical field quality compared to nitroglycerine 
intraoperative infusion at 0.5 to 10 microgram/kg/min. 
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